Exergaming to Increase Physical Activity in Overweight/Obese Children and Adolescents

Exergaming to Increase Physical Activity in Overweight/Obese Children and Adolescents

Sponsors

Lead sponsor: Norwegian University of Science and Technology

Source Norwegian University of Science and Technology
Brief Summary

The primary purpose of this study is to examine the effects of regular exergaming for 8 weeks in 24 overweight/obese children and adolescents (10-17 years) on maximal aerobic fitness (VO2max) and physical activity levels measured before and after (8 weeks) intervention period, and in addition at follow-up (12 weeks). We also wish to investigate the effects on markers of cardio metabolic health and body composition, measured at baseline, 8 weeks and 12 weeks follow-up.

Also, the participants gaming frequency will be registered throughout the 8 week period, as well as during the follow-up between 8 and 12 weeks. Aim of this study is to investigate if access to this game can provide health benefits for overweight/obese children and adolescents.

Overall Status Recruiting
Start Date February 24, 2020
Completion Date September 2021
Primary Completion Date September 2021
Phase N/A
Study Type Interventional
Primary Outcome
Measure Time Frame
Daily time physical activity (moderate, vigorous and very vigorous) 12 weeks
Secondary Outcome
Measure Time Frame
Daily average energy expenditure 8 and 12 weeks
Daily average number of steps 8 and 12 weeks
Daily time in sedentary activity (< 3.0 metabolic equivalents = METs) 8 and 12 weeks
Daily time in moderate intensity activity (3.0-6.0 metabolic equivalents = METs) 8 and 12 weeks
Daily time in vigorous intensity activity 8 and 12 weeks
Daily time in very vigorous intensity activity (>9.0 metabolic equivalents = METs) 8 and 12 weeks
Daily average total physical activity duration 8 and 12 weeks
Bioelectrical impedance 8 and 12 weeks
Blood Pressure 8 and 12 weeks
Fasting circulating glucose, as blood marker of cardiometabolic health 8 and 12 weeks
Fasting triglycerides, LDL-, HDL- and Total cholesterol, as blood marker of cardiometabolic health 8 and 12 weeks
Circulating insulin concentration, as blood marker of cardiometabolic health 8 and 12 weeks
glucose response to a 2 hour glucose tolerance test, as blood marker of cardiometabolic health 8 and 12 weeks
VO2max 8 and 12 weeks
Daily time physical activity (moderate, vigorous and very vigorous) 8 weeks
Enrollment 24
Condition
Intervention

Intervention type: Behavioral

Intervention name: Exergaming

Description: The participants in the Exergaming group will use the PlayPulse exergame for 45 minutes a minimum of two times per week for 8 weeks. Between 8 and 12 weeks the exergaming group will be provided with free access to the exergame but without the two mandatory exergaming sessions

Arm group label: Exergaming

Eligibility

Criteria:

Inclusion Criteria:

- Defined as overweight/obese for age and sex

- Able to ride a bike for up to 60 minutes

Exclusion Criteria:

- Known cardiovascular disease

- Taking beta-blockers or anti-arrhythmic drugs

- Other diseases that restrict them from doing High-Intensity Training

Gender: All

Minimum age: 10 Years

Maximum age: 17 Years

Healthy volunteers: No

Overall Official
Overall Contact

Last name: Jonathan Berg

Phone: +47 45205565

Email: [email protected]

Location
facility status contact Department of Circulation and Medical Imaging Jonathan Berg, MSc +47 45205565 [email protected]
Location Countries

Norway

Verification Date

February 2020

Responsible Party

Responsible party type: Sponsor

Keywords
Has Expanded Access No
Condition Browse
Number Of Arms 2
Arm Group

Arm group label: Exergaming

Arm group type: Experimental

Description: The participants in the Exergaming group will use the PlayPulse exergame for 45 minutes a minimum of two times per week for 8 weeks. Between 8 and 12 weeks the exergaming group will be provided with free access to the exergame but without the two mandatory exergaming sessions

Arm group label: Control

Arm group type: No Intervention

Description: Continue with normal daily routine.

Patient Data Undecided
Study Design Info

Allocation: Randomized

Intervention model: Parallel Assignment

Primary purpose: Prevention

Masking: None (Open Label)

Source: ClinicalTrials.gov